Inventor
SHIMOKAWA KENICHIRO
JP13 patents
⚠️ This page may combine multiple inventors who share the name “SHIMOKAWA KENICHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
11 patentsUS10548899B2Feb 4, 2020
Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity
TAKEDA PHARMACEUTICALS CO7 citations84
US10428056B2Oct 1, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations84
US10323027B2Jun 18, 2019
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO4 citations84
US10087150B2Oct 2, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations84
US9878989B2Jan 30, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO7 citations84
US10899752B2Jan 26, 2021
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO1 citations73
US10208046B2Feb 19, 2019
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations73
US9777005B2Oct 3, 2017
Bicyclic heterocyclic compound containing a substituted pyrrole ring
TAKEDA PHARMACEUTICALS CO5 citations73
US11034700B2Jun 15, 2021
Substituted pyrrolidine compound and use thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US11236099B2Feb 1, 2022
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations71
US12378256B2Aug 5, 2025
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations61